You are here: vision-research.eu » News

News

More than light detectors: The magic of your eyes' pupils

The mechanisms we use to sense quantity are located in our pupils. This is the result of a study conducted by the School of Psychology of the University of Sydney, in collaboration with the Universities of Pisa and Florence (Italy), recently published in Nature Communications.

New technology streamlines the development of gene therapy for genetic blinding disorders

A novel computational platform developed by researchers from the University of Pittsburgh School of Medicine identifies top-performing viral vectors that could deliver gene therapies to the retina with maximum efficiency and precision.

New project to deploy AI technology for detecting sight-threatening diabetic eye disease

St George's, University of London and Moorfields Eye Hospital NHS Foundation Trust are leading a half a million pound project on artificial intelligence (AI), funded by NHSX and the Health Foundation, and enabled by the National Institute for Health Research (NIHR).

Cartography of the visual cortex: Charting a new course for the organization of visual space

Requiring a discerning eye, mathematical precision, and keen sense of aesthetics, map making is a unique application of both art and science.

Clinically significant cataract associated with greater mortality risk from vascular causes

Clinically significant cataract is associated with an increased risk of death from vascular causes, such as stroke and heart attack, suggests research published online in the British Journal of Ophthalmology.

Nudging cells to repair damaged retinas

In an approach could someday be used to help repair the retinas in patients who have lost vision due to such diseases as macular degeneration, glaucoma and diabetes, scientists at the University of Washington School of Medicine in Seattle have induced non-neuronal cells to become retinal neurons.

Higher doses and longer use of hydroxychloroquine increase risk of severe eye complication

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk factors for retinopathy in people using hydroxychloroquine, an antimalarial drug commonly used to treat lupus, rheumatoid arthritis and other diseases.

Retinoid therapy improves vision in mice with Usher syndrome

Using data generated from patients and mice with genetic mutation for the disorder Usher syndrome, researchers from the University of Maryland School of Medicine (UMSOM), the National Institutes of Health's National Eye Institute (NEI), and National Institute on Deafness and Other Communication Disorders (NIDCD), documented the natural history of vision impairment in patients and identified the cell mechanism behind progressive vision loss.

Alcon to acquire Ivantis for $475 million

Alcon announced plans to acquire glaucoma surgery device maker Ivantis in a $475 million deal.

Researchers discover new type of nerve cell in the retina

Scientists at the John A. Moran Eye Center at the University of Utah have discovered a new type of nerve cell, or neuron, in the retina.

Clinical trial for treatment of dry eye disease clears Phase 2 hurdle

Aldeyra Therapeutics announced today that it has achieved the primary endpoint of ocular redness in its randomly assigned, double-masked, vehicle-controlled Phase 2 clinical trial in dry eye disease.

FDA approves eye drops for treatment of presbyopia

Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia.

Feinberg students practice surgical techniques on mock organs

The student-led Ophthalmology Interest Group recently held a suturing workshop, offering Feinberg students the opportunity to practice surgical techniques on mock organs. Faculty and residents were on hand to answer questions and guide students through the workshop, which was the first time many students had held a scalpel.

Increased screen time leads to more eye strain and convergence insufficiency in children

When COVID-19 first shut down classrooms and virtual schooling became the new norm, ophthalmologists predicted an increase in digital eye strain in children.

Unity reveals data from Phase 1 SAD study of UBX1325

Unity Biotechnology announces improvement in visual acuity sustained through 24 weeks following single dose of UBX1325 in Phase 1 study of patients with advanced vascular eye disease.